ImageneBio Inc
IMANASDAQHealthcare● Active
$5.63
$-0.02(-0.35%)
Market Cap$63501502
P/E Ratio—
52W High$18
52W Low$3.94
ImageneBio Inc (IMA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IMA · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.80M | $3.50M | $9.16M | $15.62M | $30.98M |
| Cost of Revenue | $1.03M | $0.00M | $1.02M | $64.32M | $47.11M |
| Gross Profit | ($0.23M) | $3.50M | $8.14M | ($48.70M) | ($16.12M) |
| Gross Margin %(computed) | -29.13% | 100.00% | 88.86% | -311.84% | -52.03% |
| Operating Expenses | |||||
| R&D Expenses | $28.52M | $32.11M | $59.65M | $64.32M | $47.11M |
| G&A Expenses | $20.73M | $8.39M | $24.93M | $22.20M | $18.02M |
| Total Operating Expenses | $48.22M | $40.50M | $83.56M | $22.20M | $18.02M |
| Operating Income | ($48.45M) | ($37.00M) | ($75.42M) | ($70.90M) | ($34.14M) |
| Operating Margin %(computed) | — | — | -823.33% | -453.99% | -110.18% |
| Interest Income | $2.04M | $7.37M | $7.11M | $2.15M | $0.02M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($45.70M) | ($36.55M) | ($68.33M) | ($68.77M) | ($34.12M) |
| Income Tax Expense | ($0.35M) | $0.01M | ($0.16M) | $0.00M | $0.00M |
| Net Income | ($45.35M) | ($36.57M) | ($68.17M) | ($68.77M) | ($34.12M) |
| Net Margin %(computed) | — | — | -744.17% | -440.29% | -110.10% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-10.76 | $-1.02 | $-1.63 | $-1.90 | $-0.95 |
| Wtd Avg Shares | 4.87M | 48.26M | 41.74M | 36.19M | 35.98M |
| EBITDA | ($47.42M) | ($35.47M) | ($74.40M) | ($70.15M) | ($33.59M) |
| EBITDA Margin %(computed) | — | — | -812.19% | -449.18% | -108.42% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more ImageneBio Inc data
About ImageneBio Inc (IMA) Income Statement
ImageneBio Inc (IMA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IMA reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -29.13%), and net income of ($0.05B) — a net profit margin of -5668.63%.
Frequently asked questions
IMA · 4 questionsImageneBio Inc (IMA) reported revenue of $0.00B for 2025, down 77.1% year-over-year.
IMA revenueIMA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09